Figure S7. Overall survival of patients in High Risk (Risk groups 4â6 of ESMO 2015 classification) stratified by Eosinophil*Neutrophil-to-Lymphocytes Ratio (ENLR) according to cut-off 0.5. (DOCX 65 kb
Figure S2. Survival curves of patients grouped by different CD8+ T cells infiltrating status (A) and...
Figure S1. Survival analysis (Kaplan–Meier estimates) with breast cancer-specific survival (BCSS) as...
The dataset: clinicopathological characteristics of the endometrial cancer patients. (XLSX 10 kb
Figure S6. Overall survival of patients in High Risk (risk groups 4â6 of ESMO 2015 classification)...
Figure S3. Overall survival according to ESMO-ESGO-ESTRO risk assessment (n = 163): high-risk (group...
Figure S5. Overall survival according to patients’ age at diagnosis (n = 163). Kaplan-Meier survival...
Figure S1. Overall survival according to FIGO stage (n = 163). Kaplan-Meier survival analysis (p = 0...
Figure S2. Overall survival according to tumour grade (n = 163). Kaplan-Meier survival analysis (p =...
Figure S4. Overall survival according to tumour histology (n = 163): endometrioid vs. non endometrio...
Table S6. Correlation analysis results of CD44, TGM2 and EpCAM plasma levels and neutrophil/lymphocy...
BACKGROUND: Systemic inflammation has long been related with adverse survival outcomes in cancer pat...
Figure S1. KaplanâMeier survival analysis of baseline hematologic parameters (NLR, PLR), TILs CD8+...
Table S1. Prognostic molecular markers in published studies. Table S2. The relationship between mole...
BACKGROUND: Systemic inflammation has long been related with adverse survival outcomes in cancer pat...
Abstract Background Systemic inflammation has long been related with adverse survival outcomes in ca...
Figure S2. Survival curves of patients grouped by different CD8+ T cells infiltrating status (A) and...
Figure S1. Survival analysis (Kaplan–Meier estimates) with breast cancer-specific survival (BCSS) as...
The dataset: clinicopathological characteristics of the endometrial cancer patients. (XLSX 10 kb
Figure S6. Overall survival of patients in High Risk (risk groups 4â6 of ESMO 2015 classification)...
Figure S3. Overall survival according to ESMO-ESGO-ESTRO risk assessment (n = 163): high-risk (group...
Figure S5. Overall survival according to patients’ age at diagnosis (n = 163). Kaplan-Meier survival...
Figure S1. Overall survival according to FIGO stage (n = 163). Kaplan-Meier survival analysis (p = 0...
Figure S2. Overall survival according to tumour grade (n = 163). Kaplan-Meier survival analysis (p =...
Figure S4. Overall survival according to tumour histology (n = 163): endometrioid vs. non endometrio...
Table S6. Correlation analysis results of CD44, TGM2 and EpCAM plasma levels and neutrophil/lymphocy...
BACKGROUND: Systemic inflammation has long been related with adverse survival outcomes in cancer pat...
Figure S1. KaplanâMeier survival analysis of baseline hematologic parameters (NLR, PLR), TILs CD8+...
Table S1. Prognostic molecular markers in published studies. Table S2. The relationship between mole...
BACKGROUND: Systemic inflammation has long been related with adverse survival outcomes in cancer pat...
Abstract Background Systemic inflammation has long been related with adverse survival outcomes in ca...
Figure S2. Survival curves of patients grouped by different CD8+ T cells infiltrating status (A) and...
Figure S1. Survival analysis (Kaplan–Meier estimates) with breast cancer-specific survival (BCSS) as...
The dataset: clinicopathological characteristics of the endometrial cancer patients. (XLSX 10 kb
DOI
Add to ORKG